Jenani, Fhaira B.

HRN: 22-19-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2022
CEFUROXIME 1.5GM (VIAL)
11/12/2022
11/18/2022
IVT
300mg
Q8
URTI
Waiting Final Action 
11/16/2022
CEFTRIAXONE 1G (VIAL)
11/16/2022
11/22/2022
IV
900mg
Now Then Q24
AGE With Mod DHN
Waiting Final Action 
11/17/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/17/2022
11/23/2022
IVT
150mg
OD
URTI
Waiting Final Action 
11/19/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
11/19/2022
11/26/2022
IV
75mg
OD
T/C Sepsis
Waiting Final Action 
11/19/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/19/2022
11/26/2022
IV
900mg
Iv
Tc Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: